Content about Connecticut

MINNEAPOLIS and ST. PAUL, Minn. — Zipnosis, which provides patient access to mainstream medicine via online diagnosis and the treatment of common health needs, has announced that its services are now available in 11 states across the country.

Patients who live in Alaska, Colorado, Connecticut, Kentucky, Maryland, Massachusetts, Minnesota, New York, Rhode Island, Washington and Wisconsin can now visit Zipnosis.com and receive a diagnosis and treatment from 8 a.m. to 8 p.m.

WILTON, Conn. — Skin care company Beiersdorf has announced a consumer awareness and fundraising initiative to support National Mentoring Month.

Beiersdorf currently has an employee-led, work-based mentoring program focused on supporting youth in the local community. In recognition of National Mentoring Month, the company, in partnership with Big Brothers Big Sisters, has created a three-month consumer awareness and fundraising initiative that will raise $100,000 to make a big difference for the Big Brothers Big Sisters network. 
 

GUILFORD, Conn. — Mitchell-Vance Laboratories on Tuesday announced that its ScarAway Silicone Scar Sheets, designed for the treatment and prevention of both hypertrophic and keloid scars, are making their debut in 3,400 Walmart locations.  

BLOOMFIELD, Conn. — Reaching out to discharged hospital patients by telephone could help reduce the chances they'll be readmitted in the future, according to a new study by a healthcare service company.

STAMFORD, Conn. — Actavis has donated $200,000 worth of medicines to help people affected by Hurricane Sandy, a charity organization said Thursday.

AmeriCares announced that it donated the antibiotics, pediatric medicines and other drugs to healthcare providers helping affected families in New York and New Jersey within days of the storm. Actavis was acquired earlier this year by Watson Pharmaceuticals.

HARTFORD, Conn. — Aetna and Cardinal Health Specialty Solutions on Tuesday announced an evidence-based program designed to improve cancer care in Michigan. This pathways initiative identifies clinical practices that improve cancer treatment and make it more affordable.

STAMFORD, Conn. – High Ridge Brands’ Alberto VO5 hair care brand has announced the upcoming launch of its new Salon Series line of shampoos, conditioners, styling and treatment products. 
 


Formulated from 100% natural oils derived from honey, papaya, kiwi, marigold, sweet almond and more, Salon Series products penetrate hair from roots-to-ends and work in tandem with VO5’s five-vitamin formula (i.e., vitamins E, H, C, B3 and B5). The suggested retail price is $2.49 each.



WASHINGTON — The Food and Drug Administration will review the safety of energy drinks containing such stimulants as caffeine in response to a letter from two senators.

GREENWICH, Conn. — Brynwood Partners VI on Monday announced that it has sold its Balance Bar Company, which manufactures nutrition and energy bars, to NBTY. 

WOONSOCKET, R.I. — In recognition of Veterans Day, CVS Caremark paid homage to nearly 50 disabled military veterans from across New England on Nov. 10, treating them to a football skills camp at Gillette Stadium in partnership with the New England Patriots.

The CVS Caremark/New England Patriots Veterans Skills Camp paired Patriots Super Bowl champions with veterans from Rhode Island, Connecticut, Massachusetts and New Hampshire for a day of fun and skills training at Gillette Stadium.

RIDGEFIELD, Conn. — Drug maker Boehringer Ingelheim has created a website designed for patients with hepatitis C and advocates, the company said Friday.

BI announced the launch of HepCRedefined.com, which it describes as an online portal to help improve the lives of those living with the virus through education, information and understanding.

FARMINGTON, Conn. – The global market for treatments for neurodegenerative disorders will exceed $20 billion before the end of the decade, according to a new report.

Global Information announced the availability of four research reports that analyze the global markets for treatments for syndromes of progressive ataxia and weakness disorders. According to GII, the global market for treatments was nearly $14 billion and is expected to reach $23.5 billion by 2017, after increasing at a five-year compound annual growth rate of 9.4%.